Introduction of novel agents in the treatment of primary CNS lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Introduction of novel agents in the treatment of primary CNS lymphoma

Published:2018-11-13 Issue:3 Volume:21 Page:306-313
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Grommes Christian¹,Nayak Lakshmi²,Tun Han W³,Batchelor Tracy T⁴

Affiliation:

1. Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York

2. Center for NeuroOncology, Dana-Farber/Brigham and Women’s Cancer Center, Boston, Massachusetts

3. Department of Hematology and Oncology and Department of Cancer Biology, Mayo Clinic, Jacksonville, Florida

4. Departments of Neurology and Radiation Oncology, Division of Hematology and Oncology, Massachusetts General Hospital, Boston, Massachusetts

Funder

National Institutes of Health

National Cancer Institute

Leukemia and Lymphoma Society

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Neurology (clinical),Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/21/3/306/27886440/noy193.pdf

Reference78 articles.

1. Primary central nervous system lymphomas in 72 immunocompetent patients: pathologic findings and clinical correlations. Groupe Ouest Est d’étude des Leucénies et Autres Maladies du Sang (GOELAMS);Camilleri-Broët;Am J Clin Pathol,1998

2. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling;Alizadeh;Nature,2000

3. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray;Hans;Blood,2004

4. A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases;Camilleri-Broët;Blood,2006

5. Ibrutinib unmasks critical role of bruton tyrosine kinase in primary CNS lymphoma;Grommes;Cancer Discov,2017

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nivolumab for CNS relapsed refractory primary mediastinal B-cell lymphoma: case report and review of the literature;Leukemia & Lymphoma;2024-09-03

2. Factors influencing timely diagnosis in neurolymphomatosis;Journal of Neuro-Oncology;2024-08-08

3. A Phase II Study Assessing Long-term Response to Ibrutinib Monotherapy in Recurrent or Refractory CNS Lymphoma;Clinical Cancer Research;2024-07-12

4. A systematic review of primary central nervous system lymphoma;Holistic Integrative Oncology;2024-05-11

5. Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO review;Neuro-Oncology;2024-04-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3